Pay in 4 interest-free payments of $32.25 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
Alzheimer's disease and polyglutamine diseases such as Spinal and Bulbar Muscular Atrophy and Huntington’s disease
In vitro: Dilute received Ready-to-use iN-LSC stock solution at 1:1000 into your neuronal reprograming medium to make the neuron induction media and use it to initiate neuronal reprogramming
Smiles: COC1=CC(=CC=C1C(O)=O)NC1=NC2=C(CN=C(C3=C(F)C=CC=C3OC)C3=CC(Cl)=CC=C32)C=N1
(2015) Nat Commun
PF-CBP1 - CBP/p300 Bromodomain Inhibitor. CAS# 1962928-21-7 Catalog No.:M60313-10S Alzheimer's disease and polyglutamine diseasesPF CBP1, CAS No. 1962928 21 7, is a potent and selective CBP p300 bromodomain inhibitor (IC50 ~125 nM for CBP and 363 nM for p300). It has >100 fold selectivity for CBP over BRD4, and shows selectivity over a panel of other bromodomains. PF CBP1 reduces LPS induced IL 1, IL 6 and IFN expression in macrophages in vitro. It can also downregulate RGS4 expression in primary cortical neurons in vitro. Product information CAS Number: 1962928 21 7 Molecular
US$ 89050.00
US$ 39950.00
US$ 34500.00
US$ 277550.00
US$ 199500.00
US$ 180.00
US$ 674.50
US$ 111.47
US$ 187050.00
US$ 21050.00
US$ 125.00
US$ 148750.00
US$ 579500.00
US$ 991000.00
US$ 64700.00
US$ 32500.00